A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Public ClinicalTrials.gov record NCT07265674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Open-label, Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients With Previously Treated Advanced Biliary Tract Cancer
Study identification
- NCT ID
- NCT07265674
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- J-Pharma Co., Ltd.
- Industry
- Enrollment
- 480 participants
Conditions and interventions
Interventions
- Nanvuranlat Drug
- Physician's Best Choice Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
- Last update posted
- May 13, 2026
2026 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope (Site 107) | Duarte | California | 91010 | Recruiting |
| University of California at Irvine (Site 101) | Orange | California | 92868 | Recruiting |
| UCLA Medical Center (Site 117) | Santa Monica | California | 90404 | Not yet recruiting |
| Mount Sinai Comprehensive Cancer Center (Site 125) | Miami Beach | Florida | 33140 | Not yet recruiting |
| Moffitt Cancer Center Magnolia Campus (Site 123) | Tampa | Florida | 33612 | Not yet recruiting |
| City of Hope - Chicago Cancer Center (Site 128) | Zion | Illinois | 60099 | Recruiting |
| University of Iowa Hospitals and Clinics (Site 126) | Iowa City | Iowa | 54242 | Not yet recruiting |
| Norton Cancer Institute (Site 115) | Louisville | Kentucky | 40127 | Not yet recruiting |
| Ochsner Medical Center (Site 120) | New Orleans | Louisiana | 70121 | Not yet recruiting |
| Karmanos Cancer Center (Site 109) | Detroit | Michigan | 48201 | Not yet recruiting |
| Masonic Cancer Center, University of Minnesota (Site 116) | Minneapolis | Minnesota | 55455 | Not yet recruiting |
| Comprehensive Cancer Centers of Nevada - Central Valley (Site 124) | Las Vegas | Nevada | 89169 | Recruiting |
| Rutgers Cancer Institute of New Jersey (Site 103) | New Brunswick | New Jersey | 08901 | Recruiting |
| Rosewell Park Comprehensive Cancer Center (Site 114) | Buffalo | New York | 14263 | Not yet recruiting |
| Memorial Sloan Kettering Cancer Center (Site 108) | New York | New York | 10065 | Not yet recruiting |
| University Hospitals Cleveland Medical Center Seidman Cancer Center (Site 111) | Cleveland | Ohio | 44106 | Recruiting |
| James Cancer Hospital and Solove Research Institute (Site 119) | Columbus | Ohio | 43219 | Not yet recruiting |
| Mercy Clinic (Site 110) | Oklahoma City | Oklahoma | 73120 | Recruiting |
| Oregan Health and Science University (Site 127) | Portland | Oregon | 97210 | Not yet recruiting |
| Allegheny Health Network (Site 121) | Pittsburgh | Pennsylvania | 15212 | Not yet recruiting |
| University of Texas Southwestern Medical Center (Site 104) | Dallas | Texas | 75390 | Recruiting |
| University of Texas MD Anderson Cancer Center (Site 102) | Hosuton | Texas | 77030 | Not yet recruiting |
| Fred Hutchinson Cancer Center Clinic (Site 122) | Seattle | Washington | 98109 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07265674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07265674 live on ClinicalTrials.gov.